Mannheimer Swartling‘s healthcare and life sciences team remains active, advising on a wide range of regulatory, dispute, and M&A matters within the space. Recently, the team has been focusing on digital compliance matters and market access models. Practice lead Camilla Appelgren is frequently engaged in licensing, clinical trials, and complex data protection issues for pharmaceutical companies, research institutions, and investors. Peter Nilsson Torres is a key contact for commercial and compliance matters, and Emmie Montgomery regularly represents clients in contentious regulatory matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team is highly knowledgeable and experienced on pharma price and reimbursement questions and knows the processes and practices of competent authorities. They are easy to work with and very accommodating to meet the sometimes strict timelines.’
- ‘Camilla Appelgren and Emmie Montgomery stand out from the team as highly knowledgeable individuals. They support the client in finding the best strategy for achieving the goals.’
- ‘This law firm stands out for its responsiveness and deep understanding of the external environment, with valuable contacts at key stakeholders. They think quickly, engage resources efficiently, and foster insightful discussions on complex topics. Their team stays well-informed of developments, ensuring proactive and strategic advice. Moreover, they deliver exceptional value for money through their efficiency and high-quality service. A truly reliable and top-tier partner!’
- ‘Camilla Appelgren is a highly pragmatic and quick thinker, consistently demonstrating effective management of team resources. Her down-to-earth approach makes her not only approachable but also highly reliable. As an expert in healthcare, she provides insightful, practical advice that is both strategic and grounded in real-world understanding. An exceptional professional who delivers results with clarity and confidence.
- ‘Mannheimer always makes sure to involve the right people for the task at hand. Collaboration is easy; everyone I have met is knowledgeable, friendly, clear and to the point.’
- ‘Camilla Appelgren is super friendly and hardworking! Likewise, Emma Montgomery and Peter Nilsson are very talented, smart and easy to work with’
Key clients
- Bristol-Myers Squibb (BMS)
- Swedish Orphan Biovitrum AB (publ) (Sobi)
- AbbVie AB
- Inceptua S.A.
- Lipum AB (publ)
- Capio AB
- Capio S:t Görans Sjukhus AB
- Janssen-Cilag
- Amgen
- Humana AB (publ)
- Impilo
- KKR
Work highlights
Advised KKR on the acquisition of Karo Healthcare to deliver “Smart choices for everyday healthcare” with a vast product portfolio (including cosmetics, medical devices, pharmaceuticals, and foods) – from EQT.
Advised EQT on its agreement to acquire a majority stake of the shares in Europa Biosite from Adelis Equity.
Assisting BMS regularly with regulatory and commercial matters.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Camilla Appelgren
Other key lawyers
Peter Nilsson Torres; Emmie Montgomery